Vaishali Thombre
Researcher
Also affiliated: Ochsner Medical Center (2021); Baptist Health Foundation (2020–2021); Colorado Kidney Care (2021)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Vaishali Thombre's research focuses on analyzing trends and financial relationships within the medical field in the United States. Her work has investigated industry payments to nephrologists and pediatric neurologists, examining data from the Open Payments Program. Thombre has also studied the demographics of neurology house staff. Additionally, her research includes exploring treatment options for neonatal opioid withdrawal syndrome, specifically the use of phenobarbital and clonidine as secondary medications. She has collaborated with researchers from the University of Arkansas at Little Rock and within the University of Arkansas for Medical Sciences.
Metrics
- h-index: 4
- Publications: 8
- Citations: 49
Selected Publications
-
Industry Payments to Pediatric Neurologists: An Analysis from the Open Payments Program (2022)
-
Trends in Demographics of Neurology House Staff in the United States (2021)
-
Industry Payments to Nephrologists in the United States (2021)
-
Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome (2021)
-
Industry payments to hospitalist physicians: a 5‐year analysis of the Open Payments programme from 2014 to 2018 (2020)
-
A Five-Year Analysis of Industry Payments to Sleep Neurologists From 2014 Through 2018 (2020)
-
A <scp>neuromuscular‐based</scp> analysis of the open payments program (2020)
-
Sham Validation in Transcranial Magnetic Stimulation (2018)
Collaboration Network
Top Collaborators
- Industry Payments to Nephrologists in the United States
- Trends in Demographics of Neurology House Staff in the United States
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
- Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
Similar Researchers
Based on overlapping research topics